Showing results (41-50 of 115) with videos related to
Sort By:
Pageof 12
Journal of Cellular and Molecular Medicine|December 9, 2017
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinibCesarina Giallongo, Nunziatina L Parrinello, Piera La Cava, et al.Journal of Clinical Medicine|March 25, 2022
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic SyndromesCalogero Vetro, Valeria Di Giacomo, Donato Mannina, et al.British Journal of Haematology|July 10, 2018
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinibElena Crisà, Daniela Cilloni, Elena M Elli, et al.Leukemia|July 24, 2025
QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasmsAndrea Duminuco, Raj Vaghela, Sukhraj Virdee, et al.Journal of Clinical Epidemiology|March 23, 2021
The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3LEva M Gamper, Francesco Cottone, Kathrin Sommer, et al.Genes|February 27, 2026
Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage ModelAndrea Duminuco, Silvia Rita Vitale, Antonella Nardo, et al.Oncotarget|March 12, 2016
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)Cesarina Giallongo, Daniele Tibullo, Nunziatina L Parrinello, et al.Frontiers in Oncology|February 24, 2025
Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasmsEsther Natalie Oliva, Shien Guo, Jennifer Lord-Bessen, et al.Leukemia & Lymphoma|September 15, 2021
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI)Paola Guglielmelli, Francesca Palandri, Carmine Selleri, et al.Biomolecules|January 22, 2021
Focus on Osteosclerotic Progression in Primary MyelofibrosisMariarita Spampinato, Cesarina Giallongo, Alessandra Romano, et al.Pageof 12